top of page

Drug-resistant TB: Rollout of shorter regimen hits a snag in South Africa

The much-anticipated rollout of the shorter regimen to treat drug-resistant tuberculosis (TB) has failed to make inroads leaving patients stranded across the country. Having started in March last year, only about 70 patients have received treatment – which is only being administered in four provinces. The new oral regimen can treat drug-resistant TB within a period of six months, instead of the usual 18 months. Read Here.
34 views0 comments

Recent Posts

See All

Treat Action Group 2023 Pipeline Report

Their annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). View the full


bottom of page